Jaejin An to Anticoagulants
This is a "connection" page, showing publications Jaejin An has written about Anticoagulants.
Connection Strength
2.606
-
Race, Ethnicity, and Language Concordance Between Patients and Physicians and Atrial Fibrillation DOAC Treatment. JAMA Netw Open. 2026 Sep 01; 9(9):e2629363.
Score: 0.907
-
Validation of electronic health record-based International Society on Thrombosis and Haemostasis bleeding algorithms in a US health system. Res Pract Thromb Haemost. 2026 May; 10(4):106616.
Score: 0.886
-
Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System. J Manag Care Spec Pharm. 2017 Jun; 23(6):700-712.
Score: 0.478
-
Effectiveness and safety of Dabigatran 110 mg versus 150 mg for Stroke Prevention in Patients with Atrial Fibrillation at High Bleeding Risk. Clin Ther. 2023 07; 45(7):e151-e158.
Score: 0.182
-
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves. Am J Cardiol. 2021 05 01; 146:22-28.
Score: 0.154